CDH1 and breast carcinoma: A recent study showed that miR-200c could inhibit EMT in breast cancer through the increase of E-cadherin (Tryndyak et al., 2010), and WAS Protein Family Member 3 (WASF3) could inhibit miR-200c expression (Teng et al., 2014).